Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE)
Brieger, David × Van de Werf, Frans Avezum, Alvaro Montalescot, Gilles Kennelly, Brian M Granger, Christopher B Goodman, Shaun G Dabbous, Omar H Agnelli, Giancarlo #
American Heart Journal vol:153 issue:6 pages:960-969
Objectives The purpose of this study is to evaluate hospital mortality and major bleeding rates among patients receiving low molecular weight heparin (LMWH), unfractionated heparin (UFH), or both, and to investigate whether concomitant glycoprotein (GP) IIb/IIIa antagonists and coronary intervention affect patterns of use and outcomes with different heparins.